BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9066982)

  • 1. Association of an exon 3 mutation (Trp66-->Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family.
    Levy E; Minnich A; Cacan SL; Thibault L; Giroux LM; Davignon J; Lambert M
    Biochem Mol Med; 1997 Feb; 60(1):59-69. PubMed ID: 9066982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trp23-Stop and Trp66-Gly mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in Denmark.
    Jensen HK; Jensen LG; Hansen PS; Faergeman O; Gregersen N
    Atherosclerosis; 1996 Feb; 120(1-2):57-65. PubMed ID: 8645371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
    Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
    Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.
    Hobbs HH; Leitersdorf E; Leffert CC; Cryer DR; Brown MS; Goldstein JL
    J Clin Invest; 1989 Aug; 84(2):656-64. PubMed ID: 2760205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New methods for rapid detection of low-density lipoprotein receptor and apolipoprotein B gene mutations causing familial hypercholesterolemia.
    Minnich A; Roy M; Chamberland A; Lavigne J; Davignon J
    Clin Biochem; 1995 Jun; 28(3):277-84. PubMed ID: 7554246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia.
    Lambert M; Assouline L; Feoli-Fonseca JC; Brun N; Delvin EE; Lévy E
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):979-84. PubMed ID: 11397707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
    Marcil M; Boucher B; Gagné E; Davignon J; Hayden M; Genest J
    J Lipid Res; 1996 Feb; 37(2):309-19. PubMed ID: 9026529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
    Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
    Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families.
    Slimane MN; Lestavel S; Sun X; Maatouk F; Soutar AK; Ben Farhat MH; Clavey V; Benlian P; Hammami M
    Atherosclerosis; 2001 Feb; 154(3):557-65. PubMed ID: 11257256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
    Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.